AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 291 min read$DRS

Leonardo DRS 2026: Revenue $1.07B, EPS $0.43— 10-Q Summary

Leonardo DRS reported Q3 2026 revenue of $1.07B, up 11% YoY, and net income of $115M, up 59.7%. EPS rose to $0.43. Nine-month revenue increased 9.2% to $2.825B, with growth in both segments. The company is investing in R&D and capacity, but FY2027 funding uncertainty may impact awards.

Original reporting
tradingview.com
Published Oct 29, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Leonardo DRS 2026: Revenue $1.07B, EPS $0.43— 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$DRSBullishMed
01

Why it matters

The disclosed revenue, net income, and diluted EPS improvements are the primary near-term drivers for sentiment, while the stated uncertainty around FY2027 funding introduces a forward risk to award timing and order conversion.

02

Market read

Traders can update positioning based on the reported quarterly and nine-month financial improvements and weigh the stated FY2027 funding uncertainty as a potential drag on future awards.

03

What to watch

Margin improvement is attributed to mix and program performance, but the article does not quantify segment margins or provide guidance, so traders may discount the durability of the margin expansion.

Relevance 7/10Novelty 6/10Timing: after-hours/filing day, based on the Oct. 29, 2026 10-Q summary

Background

The piece is an AI summary of Leonardo DRS’s SEC 10-Q filed Oct. 29, 2026, covering quarterly and nine-month results plus business highlights and a forward-looking funding uncertainty note.

Company-level read

Ticker impact

$DRSBullishMedium confidence
Context

Leonardo DRS reported 2026-period revenue of $1.07B and diluted EPS of $0.43, with net income up to $115M year over year.

Expected impact

Likely modest upside bias as investors focus on revenue/EPS improvement, tempered by caution around FY2027 funding and award timing.

Evidence & confidence

The article provides concrete quarterly and nine-month financial metrics plus a specific risk factor (FY2027 funding uncertainty) that can influence forward order conversion and margin expectations.

Market effects

Sector

Signals improving demand and backlog conversion in sensing/computing and integrated mission systems, relevant to defense electronics and mission systems suppliers.

Regional

No specific regional market effects described beyond the company’s US-listed filing.

Global

Limited global spillover; the disclosure is company-specific with no stated international contract or macro shock.

Counterpoint

What could challenge this read

The headline growth may not translate into near-term earnings power if FY2027 funding uncertainty delays awards and backlog conversion.

Key entities

  • company
    Leonardo DRS, Inc.

    Defense electronics and mission systems provider reporting 2026-period revenue, net income, and EPS in its 10-Q summary.

Read at source← All news

StoryLeonardo DRS posts strong Q3 2026 results, raises FY2026 guidance and declares dividend

Also covered by

5 outlets

Related articles

NOV 2
$DRSMed

The Army's first laser weapon production contract is for drone defense. Leonardo DRS will provide power and cooling.

Leonardo DRS (DRS) will provide power and cooling systems for AeroVironment's (AVAV) 30-kilowatt LOCUST X3 laser weapon, part of the U.S. Army's Enduring-High Energy Laser (E-HEL) program. The E-HEL is the Army's first production contract for a high-energy laser weapon system, aimed at countering unmanned aircraft threats. DRS's role supports AV's production of the LOCUST X3 for the Army's counter-UAS operations.

stocktitan.net2 min
NOV 2
$DRSMed

Leonardo DRS to supply power systems for Army laser weapon

Leonardo DRS (NASDAQ:DRS) will supply power and thermal management systems for AeroVironment's (NASDAQ:AVAV) LOCUST X3 laser weapon under the U.S. Army's E-HEL program. The contract supports the production of mobile high-energy laser systems to counter unmanned aircraft threats. DRS brings expertise in power management and environmental control systems.

investing.com2 min
NOV 1
$DRSHighAI 8/10

Leonardo DRS Earnings Call Highlights Robust Growth

Leonardo DRS reported Q3 revenue of $1.1B (+11% YoY), record bookings of $1.6B, and adjusted EBITDA of $149M (+27%). EPS grew 65% to $0.43. The company raised 2026 guidance, citing strong demand in radar, propulsion, and space sectors. Management highlighted strategic wins and investments in growth capacity.

tipranks.com3 min
OCT 29
$DRSMed

Leonardo DRS Inc (DRS) (Q3 2026) Earnings Call Highlights: Record $5.6 Billion Backlog

Leonardo DRS Inc reported a record $5.6 billion backlog. CFO Mike DePold expects IMS margins to remain at 16% and ASC margins to expand due to favorable mix. CEO John Bailloni highlighted growth opportunities in counter-UAS, space, and tactical radars, with demand from the Middle East and Eastern Europe. The company anticipates low double-digit growth in 2027, driven by increased investment and backlog.

finance.yahoo.com6 min
OCT 29
$DRSHighAI 9/10

Why are Leonardo DRS (DRS) shares soaring today

Leonardo DRS (DRS) shares rose 12% after reporting Q3 2026 revenue of $1.066B (+11% YoY) and net income of $115M (+60% YoY). The company raised its full-year 2026 guidance, including revenue to $3.95B-$3.98B and adjusted EPS to $1.50-$1.53, above consensus. Shares closed at $39.60, up 11.5%.

finance.yahoo.com4 min